DecisionView Inc., the leading
provider of business performance optimization software for the life
sciences industry, announced today the immediate availability of
StudyOptimizer 3.5 -- the industry's first business performance
optimization application for clinical trials.
Designed for pharmaceutical, biotech, CRO, medical technology companies
and academic research institutions, StudyOptimizer 3.5 automates the
clinical recruitment process with integrated predictive modeling,
analytics, simulation and rich visualization capabilities resulting in
shorter cycle times, reduced recruitment costs and improved clinical
operational efficiencies.
"Delays in recruitment are a leading cause of overall clinical trial
delays and escalating clinical trial costs. StudyOptimizer 3.5 provides
life science companies with a comprehensive application for improving the
mission critical recruitment process and achieving tangible business
results," said Steve Andrade, CEO, DecisionView.
The new version delivers dynamic recruitment planning to include
recruitment rate variables such as seasonality for developing robust
clinical recruitment plans; advanced simulation modeling and predictive
analytics that enable clinical study managers to model course corrections
and alternative recruitment strategies; and rich interactive
visualizations, including performance alerts and dashboards at the study,
country and site level. In addition, StudyOptimizer 3.5 further enhances
automated data aggregation from disparate financial and clinical systems
such as CTMS and EDC, driving improvements in clinical team productivity.
"Today's studies must reach a global patient pool and succeed in
meeting their enrollment targets. By enabling consistent planning, dynamic
performance forecasts and helpful visuals of enrollment progress,
DecisionView's StudyOptimizer can help study management teams succeed in
efficient and effective enrollment across multiple countries," said Jane W.
Schafer, Executive Director, Global Study Planning & Technical Services,
Amgen Inc.
About DecisionView
DecisionView develops innovative software solutions that optimize the
business performance of life sciences organizations around the world. By
uniquely converging predictive analytics, simulation, visualization and
data aggregation capabilities into functionally rich and easy to use
applications, the company's solutions deliver proven business value in
reducing clinical costs and improving clinical productivity. Granite
Ventures, Partech International and Adobe Ventures are primary investors in
the company.
DecisionView Inc.
decisionview